David A. Siegel Trinity Biotech PLC Transaction History

Two Sigma Advisers, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.82 - $2.94 $18,746 - $30,282	-10,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.77 - $4.18 $18,559 - $28,005	-6,700 Reduced 39.41%	10,300 $30,000
Q1 2021 May 17, 2021	SELL	$3.26 - $6.64 $25,102 - $51,128	-7,700 Reduced 31.17%	17,000 $64,000
Q4 2020 Feb 16, 2021	BUY	$1.95 - $4.77 $48,165 - $117,818	24,700 New	24,700 $94,000
Q3 2020 Nov 16, 2020	SELL	$1.68 - $3.17 $33,264 - $62,766	-19,800 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$0.88 - $2.55 $9,416 - $27,284	-10,700 Reduced 35.08%	19,800 $43,000
Q1 2020 May 15, 2020	SELL	$0.62 - $1.47 $1,488 - $3,528	-2,400 Reduced 7.29%	30,500 $34,000
Q1 2019 May 15, 2019	SELL	$2.31 - $3.22 $2,541 - $3,542	-1,100 Reduced 3.24%	32,900 $94,000
Q3 2018 Nov 14, 2018	SELL	$3.76 - $5.08 $6,392 - $8,636	-1,700 Reduced 4.76%	34,000 $136,000
Q1 2018 May 15, 2018	SELL	$5.08 - $6.06 $28,956 - $34,542	-5,700 Reduced 13.77%	35,700 $184,000
Q4 2017 Feb 14, 2018	SELL	$4.5 - $5.77 $40,500 - $51,929	-9,000 Reduced 17.86%	41,400 $212,000
Q3 2017 Nov 14, 2017	BUY	$5.16 - $5.67 $260,064 - $285,768	50,400	50,400 $283,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $49.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.